pis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They are lower because of the industry not because of the spac. Both of them went up hugely after then went ipo.
Same to you guys down in NC!
SOFI and LCID off the top of my head
ZCAR now down 60%
ZCAR down 43% spac/ipo/merger
All out of flyx from my buys yesterday in the 4's - that was a great one. Wish I had bought more shares.
Yep the trades go through but nothing up dates so it looks like you still own the equity. They are impossible to reach. Says here in messages on website:
Certain online functionality may be slow or unavailable
Date: 12/28/2023
Category: Urgent Notification
Certain online functionality may be slow or unavailable. Please do not place trades again, as duplicate orders may be created. Please check Order Status for trade execution status. We are working to resolve the issue as quickly as possible. We apologize for any inconvenience.
Glad to see it isn't just me. Been on hold for over 15min trying to talk to a rep. Account not updating.
FLYX halted again
Yes, I remember and I traded it about 10 times but managed to keep some shares.
FLYX down 64% - ipo/spac type deal
Anyone following ARM??? I bought some in Nov in the 51's and actually hung on to them. What a move.
BJDX down 30% offering priced at 1.30
On Dec 18 they did a rs 1:15
CYCC soqn 24% offering $3.315 per share - In a concurrent private placement, the company will also issue 8,000 shares at $3.315 a share, and warrants to buy up to 8,000 shares with an exercise price of $3.19 per share to members of management.
NKE down 12% disappointing earnings report - love these plays
ALVR down 53% halted three of its late-stage clinical trials following recommendations from independent data monitors and will review strategic alternatives, including a potential sale.
CANO down 17% - don't know why
POL down 42% today because co says they don't know why their stock went up 600% yesterday. lmao
EDIT - bucky already posted this one
BLUE down 45% Shares of Bluebird Bio were nearly cut in half after the company said it would price its public offering of more than 83.3 million shares at $1.50 each.
Better off closing it. Shawn have a great holiday!
they are
MCOM is a pos - reversed split - now they are delisting
MOTS down 43%- public offering priced at $1.50 a share
PCT down 43% issues that prompted a shutdown of its flagship facility in Ironton, Ohio
EDIT - it is actually a short sale not an option that needs to be cleared of settlement
EDIT 2 - Cananda and US different: The key thing for investors to remember is that it has deadlines. For investors filing their taxes in Canada, the last day for tax-loss selling in 2023 is December 27. Stocks purchased or sold after this date will be settled in 2024, so any capital gains or losses will apply to the 2024 tax year. The system differs for those filing their taxes in the US, and based on information from the IRS, the last day for tax-loss selling this year is December 29. https://investingnews.com/daily/resource-investing/mark-these-tax-loss-selling-dates-on-your-calendar/
Firstly, isn't settlement 2 days now? And you can go until the last trading day of the season to use as a tax write off without waiting until settlement. I think there are some exception like with certain options but if you are selling stock you have until the 29th.
Nothing wrong with a bearish report if you can back up your allegations.
MSS down 84% Hindenburg Researcher hit piece:
Maison Solutions is a company that took 6 California Asian-themed grocery stores public on the Nasdaq in October.
— Hindenburg Research (@HindenburgRes) December 15, 2023
The company also owns a 10% equity interest in a Dai Cheong Trading, a distribution company owned by $MSS controlling holder, Chairman and CEO, John Xu.
(1/x)
Just got back from Costco. Got a great parking space and didn't even have to wait on line to check out. It was a breeze!!
AADI down 56% on disappointing results
You can always shop Costco online if you hate it that much.
I'm going to Costco tomorrow - should I be scared?
Yeah, blame your mom.
ouch on rphm Reneo Pharmaceuticals said it will cut about 70% of its headcount and start slashing costs after a trial of its mitochondrial myopathies treatment mavodelpar failed to meet its primary and secondary efficacy endpoints.
ASYS down 30% Semiconductor co disappointing earnings - new lows 4.19 now
8k https://www.otcmarkets.com/stock/NXMH/disclosure
Item 3.02 Unregistered Sales of Equity Securities.
On or about December 5, 2023, the Company entered into an agreement for the purchase of 25,112,780 shares of the Company’s restricted Common Stock from Hiroki Tajiri, a Japanese Citizen, at a price of $0.001 per share of Common Stock. The transaction was completed, and recorded, by the Company’s transfer agent on December 11, 2023, at which time the 25,112,780 shares of common stock were cancelled and resumed the status of Treasury Shares. The total subscription amount paid by the Company was approximately $25,113. At this time, Hiroki Tajiri is not a related party to the Company.
The aforementioned sale of shares was conducted pursuant to Regulation S of the Securities Act of 1933, as amended ("Regulation S"). The sale of shares was made only to non-U.S. persons/entities (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.
Following the sale of restricted common stock to the Company, we now have 437,592,510 shares of Common Stock issued and outstanding as of the date of this report.
Item 9.01 Financial Statements and Exhibits.
I am currently using Etrade and Schwab. Etrade used to be very good. They are horrendous now in terms of customer service. Their fills are still good and they get you the best price on the fills. But they used to have a platinum team for active traders that they got rid of completely. The wait time on the phone has recently improved - I don't wait over an hour now as I did last year to speak with someone, but the knowledge of people you speak to is pale in comparison to who used to work for them. They will first screen your call by connecting you to someone who really can't do anything for you - once you explain why you are calling they transfer you to a licensed broker. I don't trade pennies anymore so I don't know if they are still considered good for that. But I do know, and this is important if you trade pennies, that if a corporate action happens they no longer waive the fee for active traders the way they used to. So if you are trading a stock that does a reverse split a(which happens often in pennies) expect to be hit with a corporate action fee.
Just last week I called them and asked them to remove two equities that were in my portfolio under a cusip from 2011 and 2014. Instead of the guy removing both, I see in my account that they are both still showing. One looking still the same and the other one saying I was short. After calling them back Monday I find out that the dumb arse who took care of the transaction removed the one stock twice instead of two different equities. So he removed the one, then he removed the same one again and it showed up as a short position and the other one he didn't touch. It's a good thing I checked this before the end of year.
Schwab is good in terms of customer service. In fact I would give them an A. I have never traded pennies with them so I don't know if they are good for that. I do know that they do NOT charge a corporate action fee to the customer.
I personally like Etrade's trading platform Pro better than Schwab's Street Smart Edge and Think or Swim.
Holy cow, Batman!
ACHV Achieve Life Sciences Inc. shares (ACHV) dropped 25% premarket on Tuesday as analysts forecasted delays in the launch of the company's smoking cessation treatment cytisinicline.
FTCH down 36% under .80
COGT down 54% - co released "positive" data BUT: company over the weekend released clinical trial data on its lead drug candidate that failed to outshine potential competitors, in analysts' view